Literature DB >> 31339048

Signatures of gene expression, DNA methylation and microRNAs of hepatocellular carcinoma with vascular invasion.

Siti A Sulaiman1, Nadiah Abu1, Nurul-Syakima Ab-Mutalib1, Teck Yew Low1, Rahman Jamal1.   

Abstract

Aim: Micro and macro vascular invasion (VI) are known as independent predictors of tumor recurrence and poor survival after surgical treatment of hepatocellular carcinoma (HCC). Here, we aimed to re-analyze The Cancer Genome Atlas of liver hepatocellular carcinoma datasets to identify the VI-expression signatures. Materials & methods: We filtered The Cancer Genome Atlas liver hepatocellular carcinoma (LIHC) datasets into three groups: no VI (NVI = 198); micro VI (MIVI = 89) and macro VI (MAVI = 16). We performed differential gene expression, methylation and microRNA analyses. Results & conclusion: We identified 12 differentially expressed genes and 55 differentially methylated genes in MAVI compared with no VI. The GPD1L gene appeared in all of the comparative analyses. Higher GPD1L expression was associated with VI and poor outcomes in the HCC patients.

Entities:  

Keywords:  HCC; TCGA; biomarker; vascular invasion

Year:  2019        PMID: 31339048     DOI: 10.2217/fon-2018-0909

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  3 in total

1.  Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis.

Authors:  Shing Cheng Tan; Poh Ying Lim; Jie Fang; Mira Farzana Mohamad Mokhtar; Ezanee Azlina Mohamad Hanif; Rahman Jamal
Journal:  Sci Rep       Date:  2020-02-26       Impact factor: 4.379

2.  A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion.

Authors:  Wei Chen; Hao Wang; Tong Li; Te Liu; Wenjing Yang; Anli Jin; Lin Ding; Chunyan Zhang; Baishen Pan; Wei Guo; Beili Wang
Journal:  BMC Med Genomics       Date:  2022-02-24       Impact factor: 3.063

3.  Bioinformatics analysis reveals the clinical significance of GIPC2/GPD1L for colorectal cancer using TCGA database.

Authors:  Zhengdong Zhao; Xinye Cui; Guoxin Guan; Yaqing Liu; Xingming Liu; Zhao Chen; Shili Ning; Fuwen Luo
Journal:  Transl Cancer Res       Date:  2022-04       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.